Results 101 to 110 of about 1,511 (168)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs

Clinical Ophthalmology, 2016
Jonathan S Lo,1 Pierre M Pang,2 Samuel C Lo3 1John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 2MD-Pacific Eye Surgery Center, Honolulu, Hawaii, 3MD-Laser and Eye Surgery Center, Honolulu, Hawaii, USA Objective: Fixed ...
Lo JS, Pang PM, Lo SC
doaj  

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study

Indian Journal of Ophthalmology, 2016
Purpose: To compare the efficacy and tolerability of brinzolamide/timolol (BT) and dorzolamide/timolol (DT) fixed combinations on intraocular pressure (IOP) reduction.
Mary S Galose, Heba M Elsaied, Tamer A Macky, Pakinam H Fouad   +3 more
doaj   +1 more source

Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nanocrystallization and tyloxapol addition

Journal of Pharmaceutical Health Care and Sciences
Abstract Background Brinzolamide (BRI) suspensions are used for the treatment of glaucoma; however, sufficient drug delivery to the target tissue after eye drop administration is hampered by poor solubility. To address this issue, we focused on nanocrystal technology, which is expected to improve the bioavailability of ...
Shuya Masuda, Shiho Yano, Tomohisa Tadokoro, Hiroko Otake, Noriaki Nagai   +4 more
openaire   +3 more sources

Brinzolamide-timolol suspension: acceptability and side effect profile

Clinical Ophthalmology, 2011
MD Doherty, SG Fraser, PS PhelanSunderland Eye Infirmary, Sunderland, Tyne and Wear, UKBackground: This study aimed to determine the frequency, nature, and impact of side effects associated with the use of brinzolamide-timolol suspension, a topical ...
Doherty MD, Fraser SG, Phelan PS
doaj  

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension

Clinical Ophthalmology, 2013
Jess T Whitson,1 Tony Realini,2 Quang H Nguyen,3 Matthew G McMenemy,4 Stephen M Goode5 1University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 2West Virginia University Eye Institute, Morgantown, WV, 3Scripps Clinic, La Jolla, CA, 4Lone ...
Whitson JT, Realini T, Nguyen QH, McMenemy MG, Goode SM   +4 more
doaj  

Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database [PDF]

, 2008
The persistence and costs of carbonic anhydrase inhibitors + prostaglandin analogues (CAIs + PGAs) vs alpha-2 adrenergic agonists + prostaglandin analogues (alpha-2 agonists + PGAs) were compared, based on The United Kingdom General Practitioner Research
Berdeaux, Gilles, Denis, Philippe, Lafuma, Antoine   +2 more
core   +2 more sources

Calidad de los ensayos clínicos sobre el glaucoma crónico [PDF]

, 2016
Introducción: El glaucoma crónico es el glaucoma más frecuente que se encuentra en la población, se caracteriza por una tensión ocular alta ya que se inicia por lo general con el aumento de la presión interna del ojo debido a un fallo de drenaje del ...
Pérez Cáceres, Ana R.
core  

Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension

Clinical Ophthalmology, 2015
Sourabh Sharma,1 Sameer Trikha,1 Shamira A Perera,1 Tin Aung1,2 1Glaucoma Department, Singapore Eye Research Institute, Singapore National Eye Centre, 2Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore ...
Sharma S, Trikha S, Perera SA, Aung T
doaj  

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

Patient Preference and Adherence, 2014
Quang H Nguyen Division of Ophthalmology, Scripps Clinic, La Jolla, CA, USA Abstract: Glaucoma is one of the leading causes of blindness and is characterized by optic nerve damage that results in visual field loss.
Nguyen QH
doaj  

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]

Clinical Ophthalmology, 2014
 Yoshikawa K, Kozaki J, Maeda H. Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol.
Yoshikawa K, Kozaki J, Maeda H
doaj